Rockville,
MD: March 27, 2009: Expression Pathology Inc. (EPI) announced
today the move of its headquarters and R&D to a new
location. Interest from academic and pharmaceutical scientists
in our tissue proteomic technology is growing rapidly.
The new facilities, in the heart of Maryland's 270
biotechnology corridor, will allow us to expand and
better support
our research
collaborations and contract services.
To subscribe to our mailing list or to ask a question,
please fill out the form below (fields with a * are required fields)
Expression Pathology Inc. is a leader in tissue proteomics.
Using our proprietary tissue
analysis platform we are developing proprietary new cancer tests
in tissue. The tests will provide information to guide treatment decisions – the
presence of protein drug targets, or which biological pathways are
activated in tumors to aid prognosis and drug selection.
Our scientists have extensive experience in pathology,
proteomics and tissue analysis. Contact us to discuss your project. We
can help you design your experiment, and we can also help you with grant
writing.
TO ORDER
Call us to discuss project or place orders on 1.301.977.3654,
American Eastern Time, 9AM to 5PM. A written order confirmation must
be faxed to 1.301.926.9283. We accept VISA and MasterCard, and purchase
orders from the United States and Canada. While we are building
our distributor network, international orders are shipped only as credit
card orders or after receipt of a wire transfer against a pro forma invoice.
